These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 31554967)

  • 1. Treatment of type 2 diabetes with the designer cytokine IC7Fc.
    Findeisen M; Allen TL; Henstridge DC; Kammoun H; Brandon AE; Baggio LL; Watt KI; Pal M; Cron L; Estevez E; Yang C; Kowalski GM; O'Reilly L; Egan C; Sun E; Thai LM; Krippner G; Adams TE; Lee RS; Grötzinger J; Garbers C; Risis S; Kraakman MJ; Mellet NA; Sligar J; Kimber ET; Young RL; Cowley MA; Bruce CR; Meikle PJ; Baldock PA; Gregorevic P; Biden TJ; Cooney GJ; Keating DJ; Drucker DJ; Rose-John S; Febbraio MA
    Nature; 2019 Oct; 574(7776):63-68. PubMed ID: 31554967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insights into IL-6 family cytokines in metabolism, hepatology and gastroenterology.
    Giraldez MD; Carneros D; Garbers C; Rose-John S; Bustos M
    Nat Rev Gastroenterol Hepatol; 2021 Nov; 18(11):787-803. PubMed ID: 34211157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the Interleukin (IL)-6 Inhibitor IL-6-RFP: fused receptor domains act as high affinity cytokine-binding proteins.
    Metz S; Wiesinger M; Vogt M; Lauks H; Schmalzing G; Heinrich PC; Müller-Newen G
    J Biol Chem; 2007 Jan; 282(2):1238-48. PubMed ID: 17085445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of gp130 receptor cytokines in the regulation of metabolic homeostasis.
    Cron L; Allen T; Febbraio MA
    J Exp Biol; 2016 Jan; 219(Pt 2):259-65. PubMed ID: 26792338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-6 Reduces Mitochondrial Replication, and IL-6 Receptors Reduce Chronic Inflammation in NAFLD and Type 2 Diabetes.
    Skuratovskaia D; Komar A; Vulf M; Quang HV; Shunkin E; Volkova L; Gazatova N; Zatolokin P; Litvinova L
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33579000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific inhibition of IL-6 signalling with monoclonal antibodies against the gp130 receptor.
    Liautard J; Sun RX; Cotte N; Gaillard JP; Mani JC; Klein B; Brochier J
    Cytokine; 1997 Apr; 9(4):233-41. PubMed ID: 9112331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cytokines cardiotrophin-like cytokine/cytokine-like factor-1 (CLC/CLF) and ciliary neurotrophic factor (CNTF) differ in their receptor specificities.
    Tormo AJ; Letellier MC; Lissilaa R; Batraville LA; Sharma M; Ferlin W; Elson G; Crabé S; Gauchat JF
    Cytokine; 2012 Dec; 60(3):653-60. PubMed ID: 22986012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression of receptors for IL-6, LIF, and CNTF in regenerating skeletal muscles.
    Kami K; Morikawa Y; Sekimoto M; Senba E
    J Histochem Cytochem; 2000 Sep; 48(9):1203-13. PubMed ID: 10950877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-6 family of cytokines induced activation of different functional sites expressed by gp130 transducing protein.
    Chevalier S; Fourcin M; Robledo O; Wijdenes J; Pouplard-Barthelaix A; Gascan H
    J Biol Chem; 1996 Jun; 271(25):14764-72. PubMed ID: 8662918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LIF and OM directly interact with a soluble form of gp130, the IL-6 receptor signal transducing subunit.
    Modrell B; Liu J; Miller H; Shoyab M
    Growth Factors; 1994; 11(2):81-91. PubMed ID: 7857660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual signaling role of the protein tyrosine phosphatase SHP-2 in regulating expression of acute-phase plasma proteins by interleukin-6 cytokine receptors in hepatic cells.
    Kim H; Baumann H
    Mol Cell Biol; 1999 Aug; 19(8):5326-38. PubMed ID: 10409724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of the signal transducer gp130 by interleukin-11 and interleukin-6 is mediated by similar molecular interactions.
    Dahmen H; Horsten U; Küster A; Jacques Y; Minvielle S; Kerr IM; Ciliberto G; Paonessa G; Heinrich PC; Müller-Newen G
    Biochem J; 1998 May; 331 ( Pt 3)(Pt 3):695-702. PubMed ID: 9560294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response to IL-6 trans- and IL-6 classic signalling is determined by the ratio of the IL-6 receptor α to gp130 expression: fusing experimental insights and dynamic modelling.
    Reeh H; Rudolph N; Billing U; Christen H; Streif S; Bullinger E; Schliemann-Bullinger M; Findeisen R; Schaper F; Huber HJ; Dittrich A
    Cell Commun Signal; 2019 May; 17(1):46. PubMed ID: 31101051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of interleukin-6-transsignaling via gp130-Fc in hemorrhagic shock and sepsis.
    Mees ST; Toellner S; Marx K; Faendrich F; Kallen KJ; Schroeder J; Haier J; Kahlke V
    J Surg Res; 2009 Dec; 157(2):235-42. PubMed ID: 19589542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the signal transducer glycoprotein 130 by both IL-6 and IL-11 requires two distinct binding epitopes.
    Kurth I; Horsten U; Pflanz S; Dahmen H; Küster A; Grötzinger J; Heinrich PC; Müller-Newen G
    J Immunol; 1999 Feb; 162(3):1480-7. PubMed ID: 9973404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of a fusion protein of human ciliary neurotrophic factor and soluble CNTF-receptor and identification of its activity.
    Sun Y; Pia M; Uwe O; Ge JG; Stefan RJ
    J Zhejiang Univ Sci; 2003; 4(3):340-5. PubMed ID: 12765290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble gp130 prevents interleukin-6 and interleukin-11 cluster signaling but not intracellular autocrine responses.
    Lamertz L; Rummel F; Polz R; Baran P; Hansen S; Waetzig GH; Moll JM; Floss DM; Scheller J
    Sci Signal; 2018 Oct; 11(550):. PubMed ID: 30279168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The membrane distal half of gp130 is responsible for the formation of a ternary complex with IL-6 and the IL-6 receptor.
    Horsten U; Schmitz-Van de Leur H; Müllberg J; Heinrich PC; Rose-John S
    FEBS Lett; 1995 Feb; 360(1):43-6. PubMed ID: 7875298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokines are a therapeutic target for the prevention of inflammation-induced cancers.
    Rose-John S; Schooltink H
    Recent Results Cancer Res; 2007; 174():57-66. PubMed ID: 17302185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel inhibitors for murine and human leukemia inhibitory factor based on fused soluble receptors.
    Metz S; Naeth G; Heinrich PC; Müller-Newen G
    J Biol Chem; 2008 Mar; 283(10):5985-95. PubMed ID: 18174171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.